By Connor Hart

Shares of Align Technology climbed after the company posted higher-than-expected profit and revenue in the first quarter, and issued an upbeat forecast despite tariff uncertainty.

The stock rose 11%, to $192.36, in after-hours trading. Through Wednesday's close, shares are down 39% in the past year.

The medical-device company after the bell posted a profit of $93.2 million, or $1.27 a share, compared with $105 million, or $1.39 a share, a year earlier.

Adjusted per-share earnings of $2.13 came in ahead of the $1.99 that analysts polled by FactSet expected.

Revenue slipped 1.8%, to $979.3 million, but topped the $975.2 million that analysts modeled.

Relating to tariffs, the company said it has clear aligner manufacturing operations in Mexico, Poland and China. It doesn't ship its clear aligners from Poland or China to the U.S., which is instead served by its manufacturing facility in Mexico.

The company's products are compliant with the United States-Mexico-Canada Agreement, though it added that it expects an incremental tariff, if implemented, to be applied to transfer prices on goods shipped from Mexico.

As tariffs currently stand, Align guided for revenue of $1.05 billion to $1.07 billion in the current quarter, the midpoint of which is in line with analyst views.

The company called for year-over-year sales growth of 3.5% to 5.5% in 2025, compared with an earlier projection for sales to rise in the low-single-digit percentage range. Analysts expect full-year sales of $4.1 billion, representing a 2.4% increase from 2024.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

April 30, 2025 19:02 ET (23:02 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.